Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-08 7:22 pm Sale | 13G | Zynerba Pharmaceuticals Inc. ZYNE | Beryl Capital Management LLC | 0 0.000% | -4,426,381 (Position Closed) | View |
| 2023-09-05 4:39 pm Purchase | 13G | Zynerba Pharmaceuticals Inc. ZYNE | Beryl Capital Management LLC | 4,426,381 8.200% | 4,426,381 (New Position) | View |
| 2023-08-24 5:23 pm Purchase | 13D | Zynerba Pharmaceuticals Inc. ZYNE | Harmony Biosciences Holdings Inc. HRMY | 7,592,498 13.130% | 7,592,498 (New Position) | View |
| 2022-02-14 3:52 pm Sale | 13G | Zynerba Pharmaceuticals Inc. ZYNE | ETF MANAGERS GROUP LLC | 3,526,304 8.560% | -1,087,028 (-23.56%) | View |
| 2021-06-01 2:00 pm Purchase | 13G | Zynerba Pharmaceuticals Inc. ZYNE | ETF MANAGERS GROUP LLC | 4,613,332 11.180% | 2,404,548 (+108.86%) | View |
| 2021-05-11 1:13 pm Purchase | 13G | Zynerba Pharmaceuticals Inc. ZYNE | ETF MANAGERS GROUP LLC | 2,208,784 5.350% | 298,590 (+15.63%) | View |
| 2021-03-11 11:12 am Sale | 13G | Zynerba Pharmaceuticals Inc. ZYNE | ETF MANAGERS GROUP LLC | 1,910,194 4.630% | -90,394 (-4.52%) | View |
| 2021-02-10 12:04 pm Sale | 13G | Zynerba Pharmaceuticals Inc. ZYNE | VANGUARD GROUP INC | 1,035,402 3.520% | -638,560 (-38.15%) | View |
| 2021-02-05 8:34 pm Sale | 13G | Zynerba Pharmaceuticals Inc. ZYNE | RAPP MICHAEL | 0 0.000% | -1,490,000 (Position Closed) | View |
| 2021-01-08 1:04 pm Purchase | 13G | Zynerba Pharmaceuticals Inc. ZYNE | ETF MANAGERS GROUP LLC | 2,000,588 6.800% | 421,427 (+26.69%) | View |
| 2020-11-16 12:05 pm Purchase | 13G | Zynerba Pharmaceuticals Inc. ZYNE | ETF MANAGERS GROUP LLC | 1,579,161 5.360% | 371,035 (+30.71%) | View |
| 2020-07-10 10:39 am Sale | 13G | Zynerba Pharmaceuticals Inc. ZYNE | BlackRock Inc. BLK | 438,643 1.800% | -1,074,962 (-71.02%) | View |
| 2020-05-11 2:43 pm Sale | 13G | Zynerba Pharmaceuticals Inc. ZYNE | ETF MANAGERS GROUP LLC | 1,208,126 4.840% | -1,475,277 (-54.98%) | View |
| 2020-02-11 4:39 pm Purchase | 13G | Zynerba Pharmaceuticals Inc. ZYNE | VANGUARD GROUP INC | 1,673,962 7.210% | 1,673,962 (New Position) | View |
| 2020-02-07 08:45 am Purchase | 13G | Zynerba Pharmaceuticals Inc. ZYNE | BlackRock Inc. BLK | 1,513,605 6.500% | 841,289 (+125.13%) | View |
| 2019-12-02 1:37 pm Purchase | 13G | Zynerba Pharmaceuticals Inc. ZYNE | ETF MANAGERS GROUP LLC | 2,683,403 8.300% | 459,630 (+20.67%) | View |